Navigation Links
Access Pharmaceuticals Presents New Data on the Company's Angiolix(R) Therapeutic Monoclonal Antibody
Date:10/2/2008

t of cancer through its affinity for a novel target, lactadherin. Lactadherin is an extracellular matrix protein that is released by numerous types of tumor cells, including most breast cancers, ovarian cancers and prostate cancer. Lactadherin has a critical role in promoting the growth of new blood vessels to support tumor growth through the activation of VEGF-mediated angiogenesis. The target lactadherin and Angiolix are supported and protected by granted patents.

About Access:

Access Pharmaceuticals, Inc. is an emerging biopharmaceutical company that develops and commercializes propriety products for the treatment and supportive care of cancer patients. Access' products include ProLindac(TM), currently in Phase 2 clinical testing of patients with ovarian cancer, and MuGard(TM) for the management of patients with mucositis. The company also has other advanced drug delivery technologies including Cobalamin(TM)-mediated targeted delivery and oral drug delivery, its proprietary nanopolymer delivery technology based on the natural vitamin B12 uptake mechanism; Angiolix(R), a humanized monoclonal antibody which acts as an anti-angiogenesis factor and is targeted to breast cancer; Prodrax(R), a non-toxic prodrug which is activated in the hypoxic zones of solid tumors to kill cancer cells; Alchemix, a chemotherapeutic agent that combines multiple modes of action to overcome drug resistance. Access is also developing Phenylbutyrate ("PB"), an HDAC inhibitor and differentiating agent currently a Phase 2 clinical candidate. For additional information on Access Pharmaceuticals, please visit our website at http://www.accesspharma.com.

This press release contains certain statements that are forward-looking within the meaning of Section 27a of the Securities Act of 1933, as amended, and that involve risks and uncertainties. These statements include those relating to: our ability to close the financing
'/>"/>

SOURCE Access Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. Access Pharmaceuticals Provides Update on Clinical Development Plan of ProLindac
2. Anesiva Completes Enrollment in Phase 3 Clinical Trial of Zingo(TM) to Treat Pain Associated With Venous Access Procedures in Adults
3. Hypertension: Journal of the American Heart Association Rapid Access Reports: Hispanics Hypertension Better Controlled With Equal Access to Care
4. Anesiva Announces Pivotal Phase 3 Trial of Zingo(TM) Meets Primary Endpoint and Significantly Reduces Venous Access Pain in Adults
5. Access Pharmaceuticals to Present Data on ProLindac(TM) at the AACR-NCI-EORTC Molecular Targets and Cancer Therapeutics Conference
6. Access Pharmaceuticals Announces Two Poster Presentations Reporting Significant Preclinical Data on ProLindac(TM) at the AACR-NCI-EORTC Molecular Targets and Cancer Therapeutics Conference
7. Demand for Spanish-Language Cancer Web Materials Quadruples; Internet Resources and Access Remain Scarce
8. New Analysis from 14 Countries Identifies Drug Access Priorities to Achieve 2010 AIDS Treatment Target
9. Access Pharmaceuticals Demonstrates Ability to Significantly Reduce Glucose Levels in Pre-clinical Testing of Cobalamin(TM) Oral Insulin
10. Childrens Hospital Cancer Study Finds Adolescents and Young Adults Dont Get Same Access to Cutting-Edge Treatment as Younger Patients
11. Insmed Provides Update on IPLEX(TM) Expanded Access Program in Italy for the Treatment of Amyotrophic Lateral Sclerosis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/20/2013)... , May 20, 2013 /PRNewswire-iReach/ -- Specific Technologies, ... first study demonstrating detection of pathogenic bacteria, including ... and Bacillus anthracis which feature ... list of potential bio-threats. This seminal study, conducted ... Laboratory, Salisbury (DSTL), ...
(Date:5/20/2013)... Sequent Medical, Inc. announced today that it ... family of WEB ® Aneurysm Embolization Devices, and ... in select neurovascular centers in Europe.  The SL family ... enable physicians to treat a broader range of aneurysms ... are made possible by further advancement of Sequent Medical,s ...
(Date:5/20/2013)... , LONDON , ... May 20, 2013 Arthroscopy ... Osteoarthritis and Preference for Minimally Invasive Procedures to Drive ... and market trends for the six arthroscopy device market ... arthroscopy implants, arthroscopy radio frequency systems, and arthroscopy visualization ...
Breaking Medicine Technology:Specific Technologies Detects and Identifies Potential Bioterrorism Pathogenic Bacteria 2Sequent Medical, Inc. Launches New SL Family of WEB Aneurysm Embolization Devices 2Increasing Prevalence of Osteoarthritis and Preference for Minimally Invasive Procedures to Drive Arthroscopy Devices Market Growth 2Increasing Prevalence of Osteoarthritis and Preference for Minimally Invasive Procedures to Drive Arthroscopy Devices Market Growth 3Increasing Prevalence of Osteoarthritis and Preference for Minimally Invasive Procedures to Drive Arthroscopy Devices Market Growth 4
... Caremark announced today that it has donated approximately $40,000 ... Joplin, MO, including some of the company,s pharmacy benefit ... by the recent tornado. CVS Caremark and CVS/pharmacy colleagues ... personal care supplies valued at approximately $35,000 to local ...
... Perma-Fix Environmental Services, Inc. (NASDAQ: PESI ... agreement with Battelle, which operates Pacific Northwest National Laboratory ... from PNNL for use with Perma-Fix,s proprietary process to ... to make Technetium 99m (Tc-99m).Tc-99m is the most widely ...
Cached Medicine Technology:CVS Caremark and Area Colleagues Provide $40,000 of Support to Tornado Relief Efforts in Joplin, MO 2Perma-Fix Signs Option Agreement to License Technology for Use in Proprietary Process to Produce Medical Isotopes 2Perma-Fix Signs Option Agreement to License Technology for Use in Proprietary Process to Produce Medical Isotopes 3Perma-Fix Signs Option Agreement to License Technology for Use in Proprietary Process to Produce Medical Isotopes 4
(Date:5/20/2013)... San Diego, CA (PRWEB) May 20, 2013 ... country and around the world will make the pilgrimage ... for the 2nd annual Digital Health Summer Summit ... two-day conference provides a unique forum to showcase the ... lessons and best practices, and network with some of ...
(Date:5/20/2013)... Chicago, IL (PRWEB) May 20, 2013 ... of innovative cloud and on-premise business process ... version 6.0 of its next-generation integration solution. ... data integration solution that seamlessly automates business ... and reporting with meaningful business user interaction ...
(Date:5/20/2013)... 20 (HealthDay News) -- Although many hospital intensive ... staff to help improve outcomes, new research suggests ... Since one-third of teaching hospitals in the ... staff a nighttime physician in the ICU, the ... doctors away from hospitals with fewer resources, the ...
(Date:5/20/2013)... 20, 2013 In celebration of National ... scientific accomplishments achieved at The Feinstein Institute for ... scientists, Advancing Women in Science and Medicine (AWSM) ... 17. Scientists, educators, business and community leaders from ... achievements of women in science. , “Women face ...
(Date:5/20/2013)... about toothpaste that transforms the sweet flavor of orange ... that mysterious sensory phenomenon in colorful, animated detail ... Society,s award-winning Bytesize Science video series at ... largest scientific society, explains that the mainstay ingredients in ... SLS for short. When you brush your teeth, SLS ...
Breaking Medicine News(10 mins):Health News:Living in Digital Times Brings Together Leaders in Digital Health for Summer Summit in San Diego 2Health News:Living in Digital Times Brings Together Leaders in Digital Health for Summer Summit in San Diego 3Health News:Living in Digital Times Brings Together Leaders in Digital Health for Summer Summit in San Diego 4Health News:Adeptia Announces New Release of Enterprise Business Integration Solution 2Health News:Adeptia Announces New Release of Enterprise Business Integration Solution 3Health News:Nighttime Docs at ICUs Don't Boost Patient Outcomes: Study 2Health News:North Shore-LIJ's Feinstein Institute Celebrates Women in Science During National Women’s Health Week 2Health News:North Shore-LIJ's Feinstein Institute Celebrates Women in Science During National Women’s Health Week 3
... HOUSTON Regardless of an individual,s dietary and lifestyle ... deprived neighborhood may increase a person,s risk for death, ... Cancer Research Conference on Frontiers in Cancer Prevention Research, ... Diet and Health Study and found that people living ...
... M.D., Professor of Medicine at Case Western Reserve University ... Medical Center has been awarded a 10 year, $19.7M ... Prevention (CDC) as an international clinical trials site for ... is a partnership of U.S. and international clinical investigators ...
... , NEW YORK, Dec. ... report is available in its catalogue: , ... http://www.reportlinker.com/p0167257/Mesenchymal-Stem-Cells-Advances--Applications.html , Mesenchymal stem cells (MSCs) are ... of cell types, including osteoblasts, chondrocytes, myocytes, adipocytes, beta-pancreatic ...
... , , Through her ... of urological patient care , BALTIMORE, Dec. 8 ... its Executive Director Sandra Vassos was presented with the Star ... Star Breakfast in New York City. The Star Award recognizes ...
... ... to hip replacement surgery in patients 20 – 60 years of age. , ... (PRWEB) December 8, 2009 -- Dr. Einhorn’s ... offers patients a less invasive alternative to hip replacement., , ,Using non-embryonic stem cells harvested ...
... , CHARLOTTE, N.C., Dec. ... the Blue Cross and Blue Shield Association (BCBSA) as ... EPLS and USA PATRIOT Act compliance solutions. Under the contract, ... its member Blue Cross and Blue Shield companies nationwide. ...
Cached Medicine News:Health News:People living in poorer neighborhoods at increased risk for death, worse health risks 2Health News:Case Western Reserve to receive $19.7m to study tuberculosis treatment drugs 2Health News:Reportlinker Adds Mesenchymal Stem Cells, Advances & Applications 2Health News:Reportlinker Adds Mesenchymal Stem Cells, Advances & Applications 3Health News:Reportlinker Adds Mesenchymal Stem Cells, Advances & Applications 4Health News:New York Women's Agenda Presents AUA Foundation Executive Director Sandra Vassos with Star Award 2Health News:New York Women's Agenda Presents AUA Foundation Executive Director Sandra Vassos with Star Award 3Health News:Leading Orthopaedic Surgeon Thomas A. Einhorn Offers Breakthrough Non-Embryonic Stem Cell Surgery to Reverse Early Necrosis of the Hip 2Health News:Leading Orthopaedic Surgeon Thomas A. Einhorn Offers Breakthrough Non-Embryonic Stem Cell Surgery to Reverse Early Necrosis of the Hip 3Health News:Leading Orthopaedic Surgeon Thomas A. Einhorn Offers Breakthrough Non-Embryonic Stem Cell Surgery to Reverse Early Necrosis of the Hip 4Health News:The National Blue Cross and Blue Shield Association Selects ATTUS Technologies as Preferred Provider for OFAC, OIG, EPLS and USA PATRIOT Act Compliance 2Health News:The National Blue Cross and Blue Shield Association Selects ATTUS Technologies as Preferred Provider for OFAC, OIG, EPLS and USA PATRIOT Act Compliance 3
The Stryker Bioabsorbable Wedge Interference Screw is made of Poly-L Lactic Acid (PLLA). The patented wedge design makes it perfect for cruciate reconstruction and is indicated for BTB and soft tissu...
The Stryker Shoulder Instrumentation Set is ideal for open and arthroscopic shoulder procedures. The kit includes all the necessary tools for bone and tissue preparation as well as suture management ...
... Arthroscopy Scissor is ideal for excising soft tissue ... in the joint. The serrated edge on the ... as hold tissue within the jaws for more ... right jaw curvatures, are the perfect tools for ...
... The Series I Instrument program offers state-of-the-art ... profile, while maintaining strength and durability. Low ... in tight joint spaces. Series I instruments ... tip style, size and angle required for ...
Medicine Products: